These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comprehensive search for Alzheimer disease susceptibility loci in the APOE region. Jun G; Vardarajan BN; Buros J; Yu CE; Hawk MV; Dombroski BA; Crane PK; Larson EB; ; Mayeux R; Haines JL; Lunetta KL; Pericak-Vance MA; Schellenberg GD; Farrer LA Arch Neurol; 2012 Oct; 69(10):1270-9. PubMed ID: 22869155 [TBL] [Abstract][Full Text] [Related]
5. The cis-regulatory effect of an Alzheimer's disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes. Linnertz C; Anderson L; Gottschalk W; Crenshaw D; Lutz MW; Allen J; Saith S; Mihovilovic M; Burke JR; Welsh-Bohmer KA; Roses AD; Chiba-Falek O Alzheimers Dement; 2014 Sep; 10(5):541-51. PubMed ID: 24439168 [TBL] [Abstract][Full Text] [Related]
6. The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ε3/ε3 genotype. Johnson SC; La Rue A; Hermann BP; Xu G; Koscik RL; Jonaitis EM; Bendlin BB; Hogan KJ; Roses AD; Saunders AM; Lutz MW; Asthana S; Green RC; Sager MA Alzheimers Dement; 2011 Jul; 7(4):456-65. PubMed ID: 21784354 [TBL] [Abstract][Full Text] [Related]
7. TOMM40 intron 6 poly-T length, age at onset, and neuropathology of AD in individuals with APOE ε3/ε3. Li G; Bekris LM; Leong L; Steinbart EJ; Shofer JB; Crane PK; Larson EB; Peskind ER; Bird TD; Yu CE Alzheimers Dement; 2013 Sep; 9(5):554-61. PubMed ID: 23183136 [TBL] [Abstract][Full Text] [Related]
8. DNA methylation of TOMM40-APOE-APOC2 in Alzheimer's disease. Shao Y; Shaw M; Todd K; Khrestian M; D'Aleo G; Barnard PJ; Zahratka J; Pillai J; Yu CE; Keene CD; Leverenz JB; Bekris LM J Hum Genet; 2018 Apr; 63(4):459-471. PubMed ID: 29371683 [TBL] [Abstract][Full Text] [Related]
9. A TOMM40/APOE allele encoding APOE-E3 predicts high likelihood of late-onset Alzheimer's disease in autopsy cases. Soyal SM; Kwik M; Kalev O; Lenz S; Zara G; Strasser P; Patsch W; Weis S Mol Genet Genomic Med; 2020 Aug; 8(8):e1317. PubMed ID: 32472747 [TBL] [Abstract][Full Text] [Related]
10. The TOMM40 '523' polymorphism in disease risk and age of symptom onset in two independent cohorts of Parkinson's disease. Bakeberg MC; Hoes ME; Gorecki AM; Theunissen F; Pfaff AL; Kenna JE; Plunkett K; Kõks S; Akkari PA; Mastaglia FL; Anderton RS Sci Rep; 2021 Mar; 11(1):6363. PubMed ID: 33737565 [TBL] [Abstract][Full Text] [Related]
11. TOMM40 and APOE variants synergistically increase the risk of Alzheimer's disease in a Chinese population. Zhu Z; Yang Y; Xiao Z; Zhao Q; Wu W; Liang X; Luo J; Cao Y; Shao M; Guo Q; Ding D Aging Clin Exp Res; 2021 Jun; 33(6):1667-1675. PubMed ID: 32725468 [TBL] [Abstract][Full Text] [Related]
12. Genotypic Effects of the TOMM40'523 Variant and APOE on Longitudinal Cognitive Change over 4 Years: The TOMMORROW Study. Zou H; Luo S; Liu H; Lutz MW; Bennett DA; Plassman BL; Welsh-Bohmer KA J Prev Alzheimers Dis; 2023; 10(4):886-894. PubMed ID: 37874111 [TBL] [Abstract][Full Text] [Related]
13. APOE ε4-TOMM40 '523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans. Yu L; Lutz MW; Wilson RS; Burns DK; Roses AD; Saunders AM; Yang J; Gaiteri C; De Jager PL; Barnes LL; Bennett DA PLoS One; 2017; 12(7):e0180356. PubMed ID: 28672022 [TBL] [Abstract][Full Text] [Related]
14. Hippocampal thinning linked to longer TOMM40 poly-T variant lengths in the absence of the APOE ε4 variant. Burggren AC; Mahmood Z; Harrison TM; Siddarth P; Miller KJ; Small GW; Merrill DA; Bookheimer SY Alzheimers Dement; 2017 Jul; 13(7):739-748. PubMed ID: 28183529 [TBL] [Abstract][Full Text] [Related]